Capital World Investors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-42,000
Closed -$25.2M 548
2024
Q3
$25.2M Hold
42,000
﹤0.01% 445
2024
Q2
$22.8M Hold
42,000
﹤0.01% 438
2024
Q1
$27M Hold
42,000
﹤0.01% 440
2023
Q4
$24.6M Hold
42,000
﹤0.01% 432
2023
Q3
$21.8M Hold
42,000
﹤0.01% 433
2023
Q2
$22.8M Hold
42,000
﹤0.01% 428
2023
Q1
$22.6M Hold
42,000
﹤0.01% 432
2022
Q4
$21.4M Hold
42,000
﹤0.01% 448
2022
Q3
$18.3M Hold
42,000
﹤0.01% 466
2022
Q2
$19.7M Hold
42,000
﹤0.01% 461
2022
Q1
$21.3M Sell
42,000
-211,575
-83% -$101M ﹤0.01% 491
2021
Q4
$134M Hold
253,575
0.02% 348
2021
Q3
$118M Hold
253,575
0.02% 357
2021
Q2
$120M Sell
253,575
-2
-0% -$960 0.02% 365
2021
Q1
$117M Buy
253,577
+2
+0% +$980 0.02% 349
2020
Q4
$135M Sell
253,575
-25,632
-9% -$12.6M 0.03% 319
2020
Q3
$134M Hold
279,207
0.03% 307
2020
Q2
$126M Buy
279,207
+237,207
+565% +$106M 0.03% 288
2020
Q1
$18.2M Hold
42,000
0.01% 407
2019
Q4
$18.4M Hold
42,000
﹤0.01% 433
2019
Q3
$17.5M Buy
42,000
+41,075
+4,441% +$16.8M ﹤0.01% 420
2019
Q2
$333K Buy
+925
New +$309K ﹤0.01% 520

Other funds holding CHE

Capital World Investors's CHE Position: Q4 2024 in Review

Capital World Investors sold out of Chemed (CHE) in Q4 2024, closing a stake of 42,000 shares — an estimated $25.2M sold.

Capital World Investors first reported a position in CHE in Q2 2019 and held it in 22 quarters. The position peaked at $135M in Q4 2020. 528 funds tracked by Wall St. Rank hold CHE as of Q4 2024.

  • Capital World Investors reported no remaining Chemed position as of Q4 2024 after selling out during the quarter.
  • Capital World Investors sold 42,000 Chemed shares in Q4 2024, an estimated $25.2M.
  • Capital World Investors first reported a position in Chemed in Q2 2019 and held it in 22 quarters.
  • Capital World Investors's Chemed position peaked at $135M in Q4 2020.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q4 2024.

Based on Capital World Investors's 13F filing for Q4 2024, filed 13 Feb 2025.